BIO 2026 | Alexander Seyf | Autolomous

How do we take cell and gene therapies from boutique, ultra-rare treatments to scalable, mainstream medicine?

In this episode of Partner.bio at BIO International Convention 2026, we connect with Alexander Seyf the multidisciplinary mind behind Autolomous. With a background spanning mathematics, physics, astronomy, and early artificial intelligence, Alexander brings a unique, systems-level perspective to the biotech sector.

In this interview, he and Aaron break down the critical manufacturing barriers holding back advanced therapeutics and why a digital revolution is no longer optional for the life sciences industry.